Key Findings Demonstrating Impact of Shellpak® Adherence Packaging
MWV Healthcare is committed to developing packaging solutions that help our customers improve patient medication adherence and reduce medication error and the overall cost of health care.
To understand the state of adherence data, MWV recently sponsored a systematic review of randomized controlled trial evidence of the adherence benefits of adherence packaging interventions. Results highlight the need for high-quality trials to better assess those benefits. (Zedler et al., Clinical Therapeutics / Vol 33, Number 1, 2011: 62–73)
To address that data gap, MWV funded this unprecedented, peer-reviewed study which evaluates the real-world effectiveness of Shellpak adherence-designed packaging compared with traditional pill vials on patient adherence.
Shellpak demonstrated a statistically significant benefit over vials as measured by length of therapy (LOT) and proportion of days covered (PDC).
No additional patient educational materials or programs accompanied the packaging. Additional supportive interventions in an adherence program would likely result in even greater adherence improvement.
“An adherence strategy of even small effect size that is broadly implemented on a population level could significantly leverage therapeutic effect and provide substantial cumulative public health benefit. ”
– Zedler et al. Clin Ther
Case Study: Optimizing Brand Value with Innovative Packaging Solutions (PDF)
Read how we optimized value for a top pharmaceutical manufacturer's leading branded anti-hypertensive with our innovative packaging solutions in conjunction with communications.